– Reuters
Syros Pharmaceuticals Granted Canadian Patent Titled ‘HETEROAROMATIC COMPOUNDS USEFUL FOR THE TREATMENT OF PROLIFERATIVE DISEASES (E.G., CANCERS, LEUKEMIA, AUTOIMMUNE DISEASES)’
https://www.ic.gc.ca/opic-cipo/cpd/eng/patent/2927917/summary.html